← Database
Neuropeptide

DSIP

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

An endogenous peptide associated with sleep modulation and stress responses; older human studies are mixed and it is not an approved therapy.

How it works

DSIP (delta sleep-inducing peptide) is a naturally occurring peptide first identified in the 1970s for its apparent link to deep sleep.

Despite decades of study, its exact receptor and mechanism remain poorly defined. It's proposed to modulate sleep patterns, the body's stress (HPA) axis, and the opioid and GABA systems — but these remain loosely characterized.

Reflecting that uncertainty, the older human data are mixed, and it is not an approved therapy. It's a good example of a peptide where the honest 'how it works' answer is largely 'we don't fully know.'

Mechanism · Detailed Analysis
Molecular targetAn endogenous nonapeptide whose receptor and precise mechanism remain poorly defined.
Proposed downstream effectsProposed modulation of sleep architecture, the HPA/stress axis, and opioidergic/GABAergic systems.
Evidence & caveatsDespite decades of study the mechanism is unclear and human data are mixed and dated.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.